Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CYTARABINE\DAUNORUBICIN Cause Epistaxis? 40 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 40 reports of Epistaxis have been filed in association with CYTARABINE\DAUNORUBICIN. This represents 2.0% of all adverse event reports for CYTARABINE\DAUNORUBICIN.

40
Reports of Epistaxis with CYTARABINE\DAUNORUBICIN
2.0%
of all CYTARABINE\DAUNORUBICIN reports
7
Deaths
28
Hospitalizations

How Dangerous Is Epistaxis From CYTARABINE\DAUNORUBICIN?

Of the 40 reports, 7 (17.5%) resulted in death, 28 (70.0%) required hospitalization, and 5 (12.5%) were considered life-threatening.

Is Epistaxis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CYTARABINE\DAUNORUBICIN. However, 40 reports have been filed with the FAERS database.

What Other Side Effects Does CYTARABINE\DAUNORUBICIN Cause?

Febrile neutropenia (394) Acute myeloid leukaemia (175) Pyrexia (157) Death (147) Sepsis (126) Off label use (119) Pneumonia (118) Rash (109) Acute myeloid leukaemia recurrent (83) Disease progression (79)

What Other Drugs Cause Epistaxis?

RIVAROXABAN (5,629) ASPIRIN (3,214) APIXABAN (2,831) FLUTICASONE (1,745) TREPROSTINIL (1,726) CLOPIDOGREL BISULFATE (1,560) BEVACIZUMAB (1,542) WARFARIN (1,498) PALBOCICLIB (1,280) ADALIMUMAB (1,243)

Which CYTARABINE\DAUNORUBICIN Alternatives Have Lower Epistaxis Risk?

CYTARABINE\DAUNORUBICIN vs DABIGATRAN CYTARABINE\DAUNORUBICIN vs DABIGATRAN ETEXILATE CYTARABINE\DAUNORUBICIN vs DABRAFENIB CYTARABINE\DAUNORUBICIN vs DABRAFENIB\TRAMETINIB CYTARABINE\DAUNORUBICIN vs DACARBAZINE

Related Pages

CYTARABINE\DAUNORUBICIN Full Profile All Epistaxis Reports All Drugs Causing Epistaxis CYTARABINE\DAUNORUBICIN Demographics